NCT01186328 2024-02-01EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)Therapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Terminated6 enrolled 11 charts